Keywords: adolor, investigate, adl, 2-1294, corneal, pain, emerging

Adolor To Investigate ADL 2-1294 In Corneal Pain

Article | 30 June 1998

Print This

Emerging pharmaceutical company Adolor Corp, based in Pennsylvania,USA, has begun Phase I trials of its lead compound ADL 2-1294, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in